IO Biotech Statistics Share Statistics IO Biotech has 65.88M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 65.88M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 28.94% Shares Floating 49.27M Failed to Deliver (FTD) Shares 200 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 1.48M, so 2.25% of the outstanding
shares have been sold short.
Short Interest 1.48M Short % of Shares Out 2.25% Short % of Float 4.7% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.63 and the forward
PE ratio is -1.79.
IO Biotech's PEG ratio is
0.02.
PE Ratio -0.63 Forward PE -1.79 PS Ratio 0 Forward PS 7.9 PB Ratio 1.29 P/FCF Ratio -0.74 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for IO Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.33,
with a Debt / Equity ratio of 0.04.
Current Ratio 3.33 Quick Ratio 3.33 Debt / Equity 0.04 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.19M Employee Count 80 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1.44M Effective Tax Rate -1.53%
Stock Price Statistics The stock price has increased by 98.86% in the
last 52 weeks. The beta is 0.41, so IO Biotech's
price volatility has been higher than the market average.
Beta 0.41 52-Week Price Change 98.86% 50-Day Moving Average 1.76 200-Day Moving Average 1.18 Relative Strength Index (RSI) 51.19 Average Volume (20 Days) 3,094,795
Income Statement
Revenue n/a Gross Profit -849K Operating Income -95.18M Net Income -95.49M EBITDA -93.2M EBIT -94.05M Earnings Per Share (EPS) -1.45
Full Income Statement Balance Sheet The company has 60.03M in cash and 1.92M in
debt, giving a net cash position of 58.12M.
Cash & Cash Equivalents 60.03M Total Debt 1.92M Net Cash 58.12M Retained Earnings -359.31M Total Assets 42.33M Working Capital 19.08M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -82.35M
and capital expenditures -44K, giving a free cash flow of -82.39M.
Operating Cash Flow -82.35M Capital Expenditures -44K Free Cash Flow -82.39M FCF Per Share -1.25
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
